InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the complete record of transactions filed by Olivier Soula, Chief Executive Officer. Director active across 1 company, notably ADOCIA. In total, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €150k. Activity tracked since 21 March 2024. The latest transaction was disclosed on 21 March 2024 (Acquisition). Regulator: AMF. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Olivier Soula is the Chief Executive Officer of ADOCIA, a company focused on developing innovative treatments for diabetes and other metabolic diseases. Under his leadership, ADOCIA is committed to improving patients' lives through advanced therapeutic solutions. Olivier Soula has extensive experience in the pharmaceutical and biopharmaceutical sectors, enabling him to guide the company towards new heights of innovation and growth.